The question of early detection of lung cancer may still be a subject to a surgical treatment. However, this may change. A company called BioSystems, which specializes in finding innovative cancer diagnostics, has worked on a blood test for detecting a tumor.

BioSystems identified thirteen specific antibodies in lung cancer, which “revealed a very good sensitivity, greater than 80%,” says its CEO, Jean-Pierre Tirouflet, in Le Parisien on Monday. He recalled that “the PSA, which is only tested for prostate cancer, shows a sensitivity of 35%.”